
Moncef Slaoui, a former pharmaceutical executive, is now overseeing the U.S. initiative to development coronavirus treatments and vaccines. His financial interests and corporate roles have come under scrutiny.
By BY SHEILA KAPLAN, MATTHEW GOLDSTEIN AND ALEXANDRA STEVENSON from NYT Health https://ift.tt/2WO6BlD
via IFTTT
Coronavirus (2019-nCoV), Appointments and Executive Changes, Venture Capital, Conflicts of Interest, Vaccination and Immunization, Drugs (Pharmaceuticals), Stocks and Bonds, United States Politics and Government, Biotechnology and Bioengineering, Ethics and Official Misconduct, Boards of Directors, Research, your-feed-healthcare
Source New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét